Monitor whether the warrants are exercised for cash or on a cashless basis, as this will determine if the company receives any capital. The stock price relative to the $4.06 exercise price is critical; if it stays below, cashless exercise is more likely, providing no cash to the company.
Executive Summary
BIO-key International filed Amendment No. 1 to its S-1 registration statement to register the resale of up to 1,236,668 shares of common stock issuable upon exercise of warrants held by Armistice Capital Master Fund Ltd. The company will not receive any proceeds from the resale, but could receive up to ~$5.0 million if the warrants are exercised for cash, contingent on stockholder approval which was obtained on October 30, 2026. The filing highlights the company's ongoing need for capital, its history of losses, and a going concern qualification from its auditor.
Key Facts
- Registers resale of up to 1,236,668 shares of common stock by Armistice Capital Master Fund Ltd.
- Company will not receive any proceeds from the resale of shares.
- If all warrants are exercised for cash at $4.06 per share, company would receive aggregate gross proceeds of approximately $5,020,872.
- Stockholder approval for warrant exercise was obtained on October 30, 2026.
- As of October 28, 2026, there were 2,035,149 shares of common stock outstanding.
- Assuming full warrant exercise, shares offered represent approximately 38% of outstanding common stock.
- The company has a history of losses and its auditor's report includes a going concern qualification.
- The warrants have a five-year term and include a beneficial ownership limitation of 4.99% (or 9.99% at holder's election).
- The closing price of common stock on October 29, 2026 was $2.93 per share.
- Market cap is approximately $6 million.
Financial Impact
Potential gross proceeds of up to $5.0 million if warrants are exercised for cash, but no proceeds from the resale itself. The filing represents potential dilution of ~38% of current outstanding shares.
Risk Factors
- Potential significant dilution of ~38% if warrants are exercised.
- Company may not receive any cash proceeds if warrants are exercised on a cashless basis.
- History of losses and going concern qualification indicate financial distress.
- Low market cap ($6M) and high short interest (~19% of shares) suggest volatility.
- Multiple recent equity-linked financings indicate persistent need for capital.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1/A Filing (Primary) | 0001437749-26-034238 |
| Exhibit: ex_1033859.htm | 0001437749-26-034238 |
| Document: 0001437749-26-034238-index-headers.html | 0001437749-26-034238 |
| Document: 0001437749-26-034238-index.html | 0001437749-26-034238 |
| Document: 0001437749-26-034238.txt | 0001437749-26-034238 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 30, 2026 1d ago | S-1/A | $2.90 | awaiting T+60 | awaiting T+60 | $2.70 (+6.90%) |
Oct 9, 2026 22d ago | S-1 | $1.65 | awaiting T+60 | awaiting T+60 | $2.70 (−63.64%) |
Oct 6, 2026 25d ago | DEFA14A | $1.76 | awaiting T+60 | awaiting T+60 | $2.70 (+53.41%) |
Oct 6, 2026 25d ago | 8-K | $1.76 | awaiting T+60 | awaiting T+60 | $2.70 (+53.41%) |
Oct 2, 2026 29d ago | 8-K | $1.93 | awaiting T+60 | awaiting T+60 | $2.70 (−39.90%) |
Sep 29, 2026 4w ago | Press Release | $3.12 | awaiting T+60 | awaiting T+60 | $2.70 (−13.46%) |
Aug 24, 2026 9w ago | DEFA14A | $2.97 | awaiting T+60 | awaiting T+60 | $2.70 (+9.09%) |
Aug 14, 2026 11w ago | 8-K | No price | awaiting T+60 | awaiting T+60 | No price |
Aug 13, 2026 11w ago | Press Release | $3.18 | awaiting T+60 | awaiting T+60 | $2.70 (−15.09%) |
Aug 10, 2026 11w ago | Press Release | $4.17 | awaiting T+60 | awaiting T+60 | $2.70 (−35.25%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers